3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Myasthenia Gravis
1
Interventions
efgartigimod alfa
2
Rituximab
2
Hizentra
2
zilucoplan
1
thymoglobulin
1
rozanolixizumab
1
rhoA GTP-Binding Protein
1
prednylidene
1
iscalimab
1
inebilizumab
1
gamma-Globulins
1
eculizumab
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
apraclonidine
1
Sternotomy
1
Prednisone
1
Peripheral Blood Stem Cell Transplantation
1
Methotrexate
1
Melphalan
1
Immunoglobulins, Intravenous
1
HBM9161
1
Fluid Therapy
1
Etoposide
1
Cytarabine
1
Carmustine
1
CK-2017357
1
Bortezomib
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Myasthenia Gravis
×
Sternotomy
×
Clear all
NCT02317224
2014-12-15
3-Hole
Tang-Du Hospital
Phase 2
Unknown
240 enrolled